mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
0.11 |
0.5 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.5 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.5 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.5 |